Breast Surgery International (BSI) was formed in 1999 as an integrated society within the International Surgical Society ISS/SIC. One goal is to promote breast surgery world wide and focus on the situation in the developing countries.
BACKGROUND
International Surgical Society -S ociété Internationale de Chirurgiecelebrated its centennial anniversary in 2001. In 1999 during the 38 th world congress of surgery it accepted as its eighth integrated society Breast Surgery International (BSI). The goal of this society is to promote breast surgery world wide. The society has accrued 120 members from 20 nations.
One major working task for the society after strong motion from the founding members, has been to specifically address the situation in the developing countries. It was decided by the membership assembly that each International Surgical Week's BSI program should contain as ymposium addressing the breast diseases in developing countries. This paper contains an edited summary of asymposium presented at the International Surgical Week in 2001 when locally advanced breast cancer (LABC) in two African countries and in Malaysia was highlighted. The data presented encompass personal experiences and opinions from the contributing authors (J.P.A, E.U.A, E.M.M., H.A.) who all have strong clinical commitments to breast cancer care. In addition aMedline search was undertaken to add data on the global breast cancer panorama. This paper will not cover therapeutic recommendationsinreference to thesituation in thedeveloped countries except for certain quoted publications.
GLOBAL INCIDENCE
Breast cancer is the most common cancer in women in most parts of the world (1) ( Fig. 1 ). Its calculated incidence is highest in Western Europe, North America, Australia and New Zealand. It is intermediate in Eastern European countries and Japan, whereas Asia, Africa and South America have the lowest incidence (2). In the year 2000 there were one million cases of breast cancer reported worldwide with 373 000 deaths. In more developed countries the incidence was averaged at 95 per 100 000 and in less developed countries it was averaged at 20 per 100 000 population (3).
DIVERGING RESOURCES
There is an argument that communicable diseases matter more than non-communicable ones such as cancer,i nt he world's2 0% poorestp eoples.H owever, in the large populations of developing countries the number of breast cancer deaths is actually highestimated to account for more than 50 %o fb reast cancer deaths worldwide. China and Southern Asia, even with low incidence rates, contribute almost as many breast cancer deaths worldwide as North America and more than Western Europe (4). Breast cancer is usually diagnosed at amore advanced stage in developing countries and for this and other reasons in general these regions have higher mortality ratios for breast cancer than the United States and Western Europe (4). The Djerba Statement in 1995 stated that factors attributing to cancer incidence and cancer death rates in developing countries were increased life expectancy, life style changes and environmental degradation (5) .
There are many difficulties regarding treatment that are specific for developing countries. Resources for breast cancer treatment may be virtually lacking or very limited. It is probably more correct to describe developing countries as countries with limited resources (6). In more than 30 countries there is no access to radiotherapy facilities at all, although the WHO recommends an absolute minimum of 0.4 therapy machines per million of population. The lack of resources may seem an insuperable problem but it should be noted that the cost of one military jet fighter represents the entire costs for radiotherapy services for most countries. Together with surgery radiation therapy is the most cost-effective way of curing cancer (7). The cost of treating breast cancer in developing regions is probably only 5%or less per patient of the cost in developed regions (4). Apart from simple lack of treatment resources, lack of access to facilities may be aproblem.
Aseries of guidelines and national treatment protocol prevail to assist clinicians and consumers in developing countries (8-10). For early breast cancer breast conservation has become the dominant option and it is safe method when combined with radiation therapy. Thereisevidencetosupport adjuvant treatment to the majority of patients with early breast cancer and with LABC will prolong survival and reduce locoregional recurrence rates (10, 11). The prevalence of LABC is estimated to approximately 20 %inWestern hospital series but in countries with different social and cultural background this figure is much higher. 
CLINICAL SCENARIO
While screening for breast cancer is ah ealth policy goal, neither the infrastructure nor the personnel resources are available to roll out breast cancer screening in developing countries. Ag radual approach, starting with breast nurses performing clinical breast examinations in dayclinics in thevicinityofacademic centers was suggested in 2000 in South Africa but has still not been implemented (J. P. Apffelstaedt, Discussion paper, Breast Cancer Screening in South Africa National Department of Health Pretoria 2000).
At the Breast Clinic of the University of Stellenbosch, the referral center for cancer therapy of apopulation of about 3million in the Western Cape Province of South Africa, stage at presentation has been stable over the last 10 years with 10 %ofpatients presenting with stage Iw hile 30 %o fp atients, each present with stages II, III and IV disease. Surgical therapy is readily available, including advanced options such as immediate breast reconstruction with free tissue transfer. Sentinel lymph node adenectomy is done routinely. Nevertheless, waiting times for radiotherapy (palliative and adjuvant) can exceed four months. The equipment is on average 30 years old and break-downs are common. Mammography is performed on a1 5-year old machine and there is no budget for ar eplacement of either radiotherapy or mammography equipment. Chemotherapy is largely limited to CMF (cyclophosphamide methotrexate and fluorouracil and CAF (cyclophosphamide, adriamycin fluorouracil) regimens, newer agents such as Navelbine, Taxanes and Herceptin are not available, neither are aromatase inhibitors.
At the breast cancer unit at Groote Schuur Hospital in Cape Town, South Africa, only 6% of black breast cancer patients, as opposed to am uch higher proportion of those of mixed or white race, accept the recommended treatment for breast cancer (12) .
The reasons for this are of religious and social nature, e.g.: patients believe to have been poisoned by an evil sorcerer and that special indigenous African medicines are required; patients also often believe that Western treatment, such as surgery, will spread the cancer. Decision-making may involve various family members, including older conservative family members and financial implications may also prevail and affect negatively on accepting treatment. Patients also do not wish to be stigmatized by being seen attending acancer unit (12) .
In Nigeria, depending on the environment, culture, level of awareness and other factors, breast cancer is the leading cause of death next to cancer of the cervixuteri in womenaged30to50years.Itisassumed that 90 %ofdiagnosed breast cancer is inoperable at the time of diagnosis. Duration of symptoms in an unpublished survey (E.A.Personal communication 2001) was from less than one month to well over 36 months. The commonest type of breast lesion was breast cancer followed by fibroadenoma. The male to female ratio was 1:9 to 1:7. The age range for females was 20-81 years and males 40-70 years with the peak generally at 31-50 years. Parity ranged from 0-17 with am ean of 5-6 and ap eak of 7-8. Breast-feeding was 100 %w ith an average duration of 18 months. Over 70 %o fp atients presented with locally advanced/metastaticdisease; morethan90%had axillary node enlargement at diagnosis; more than 20 %w ere pregnant and more than 70 %p remenopausal. Most patients present with anemia and deranged electrolytes and urea. There is no unified treatment protocol. Various types of mastectomy with or without axillary clearance were done. Some patients had preoperative chemotherapy CMF, which was continued postoperatively. Some had hormonal therapy in combination with surgery and chemotherapy. Only about 2% had radiotherapy as adjuvant treatment. Histopathologically, more than 80 %h ad invasive ductal carcinoma and the rest non-Hodgkin's lymphoma, sarcoma, etc. Hospital stay varied from two to four weeks. By two years, only about 18 %o fp atients returned for follow up and by six years, only about 6%.T he fate of the rest of the patients can only be imagined. Most articles state that parity and breast-feeding protectfrombreast cancer. The authors of such publications base their statements on the study of women in Europe and parts of the United States where parity is about two. In developing countries, the average parity is 5.6 while breast-feeding is 100 %! The speculative question arises: if the repeated trauma caused by the child pulling the breast in different directions, with occasional biting and beating while the mother is busy attending to some household chores e.g. cooking, washing clothes, etc. is ac ontributory negative factor. In the average developed countries, the mother normally devotes available time to breast-feeding, often devoid of distressful diversions. The breasts are handled with care by the babies because there is enough milk, love and care from the mother! Breast cancer is the commonest cause of cancer death among women in Malaysia. (13) . In the year 2000 there were 3825 new cases of breast cancer reported with 1707 deaths from the disease. The incidence was estimated to be at 35 per 100 000 population. This figure is low in comparison with Singaporean women who had an incidence of 54 per 100 000 population (14) . Apparently this difference may be attributed to the difficulty in getting accurate statistics and under reporting of cases. Evaluation and assessment of the breast clinic service in Malaysia in 1997 showed that only 16 operational breast clinics were available for ap opulation of 21 million. There is gross disparity in the implementation, which falls far short of declared policies. Due to shortage of resources and manpower in every category the standards and progress of breast clinics throughout the country have been stagnant. The breast clinic in Kuala Lumpur Hospital diagnosed approximately 200 new cases of breast cancers ay ear since 1993. This figure represents approximately 15 %ofthe total clinical panorama of breast diseases. Over the last four years only 5%(n =40) of atotal of 774 cases of newly diagnosed breast cancer were impalpable. Stage III and IV is the commonest presentation (50-60 %o f cases). The peak age groups among the three major ethnic distributions ranged from 40-49 years of age. Half of all new cases were below the age of 50, 17 % were below the age of 40 and 2%below the age of 30. (Median age: 50 years in Chinese, in 44 years in Malays and in 53 years in Indian ethnic group). The mean tumorsizeatpresentationwas four cm butthe tumor size was much larger in Malay ethnic group. Over the years in this urban hospital, despite active breast cancer campaign and awareness program being undertaken, stage at presentation remained unchanged. The percentage of advanced breast cancer is estimated to be much higher in rural hospitals. From at otal of 1,303 women registered attending a Malaysian Well Person's Clinic program at as tate Hospital, only two percent of women were taught and practiced breast self-examination (13) .
Surgery continues to be the main deterring factor for Malaysian patients. In Kuala Lumpur Hospital approximately 5%of breast cancer patients decline further treatment. Although it would seem that this perception may occur predominantly in the less educated patients this phenomenon is also affecting the educated patients. Fear, doubt and denial may be accountable for such delays. It would seem that social cultural perception of breast cancer in Malaysia is the main obstacle to the successful implementation of a breast cancer-screening program. There are multiple reasons why the rate of LABC remains so high in Malaysia and it may take adecade or two to educate and create awareness in women towards health seeking behavior. It is thus erroneous to believe that the social perception of breast cancer is geographically and culturally interchangeable.
DISCUSSION
The impact on outcome of preventive, early detection and therapeutic interventions differs for specific cancer sites. For instance for lung, liver and stomach cancer treatment options are limited but preventive measures can have large impact. Cervix cancer and breast cancer benefit from early detection whereas leukemia and testicular cancer can be curable diseases, however only applicable when effective treatments prevail (15) .
Breast cancer in the developed countries is the foremost studied malignancy and its management and treatment relies on data from the last three decades of randomized trials supporting and mostly offering multimodality treatment. The data here presented clearly show as cenario with increasing cancer rates and limitations in detection, management and care. Breast cancer affects younger women and more often men than in developed countries. Maintaining high standard mammography requires an unbroken chain of high standard that involves equipment, personnel, administration and complying patients which makes this screening method questionable in societies with restrained resources. There is no population screening program in any of the three countries described. Breast self examination and awareness of symptoms is probably am ore justifiable approach (16) . From the regional perspectives of breast cancer in developing countries it is obvious, that surgery is the most readily available treatment modality. There is at rend towards induction chemotherapy, aregimen which may not be applicable for LABC in situations where resources are limited. It demands monitoring for clinical tumor response rates, tolerability and timing when to precede to other treatment modalities. The chemotherapeutic compounds and associated drugs are complex that cannot be afforded within ar estrained budget. Hormonal treatment with or without concomitant chemotherapy in hormone receptor positive women prolongs life in LABC (10). As hormonal treatment in relation to chemotherapy is inexpensive it seems reasonable to obtain estrogen and progesterone receptor status for women with breast cancer. LABC is a heterogeneous disease, therefore most authors recommend multimodality therapy including chemotherapy, hormonal treatment, surgery and radiotherapy to reduce overall morbidity of treatment (10). Collaboration between surgeons and oncologists is a prerequisite.
Social and culturalp roblems, which are currently the most important impediment to the provision of adequatec are to breast cancer victims in countries with limited resources, will only be overcomeaseducation and socioeconomic status improve. In reviewing this problem in countries with limited resourcesi tw ould appear that oncologistsi nt he developed and developing world can play av ital role through international associations by urging governments to supply resources and by insisting on training programs together with equipment provision. (6, 17). Fear, anxiety and sociocultural barriers have been implicated to the practice of breast cancer screening, ap henomenon also seen in immigrant women residing in the US (18, 19) .
The current situation as described herein clearly shows the complexity of managing breast cancer in different societies. An international association such as BSI can contribute to establish aforum where experiences are shared globally and where education and scientific collaboration are interchanged in all fields of breast diseases. BSI has an existing international faculty that is willing to give education to trainees under different concepts (20). BSI has also undertaken the task to organize postgraduate workshops in conjunction with the International Surgical Weeks.
